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Summary Recent advances in molecular biological techniques have yielded large amounts of
information regarding the oral microflora. The microbiological communities were shown to be
more diverse than previously thought and to include a number of previously uncharacterized
microorganisms. The range of research targets of microorganisms associated with oral diseases
has been expanded to include these unknown or uncharacterized organisms. These organisms
include the Archaea. A series of recent reports suggested these microorganisms to be potential
pathogens involved in periodontitis and apical periodontitis mainly based on the detection
frequency or their increased numbers in diseased sites in association with the severity or
symptoms of disease. However, it cannot be concluded that Archaea are oral pathogens based
on such circumstantial evidence. Further studies are required to investigate the potential
pathogenic mechanisms of action of these organisms. This will require investigation of the
antigenic properties of the Archaea and synergism with other established oral pathogens.
Especially, studies of the host immune response will provide insight into the medical impact
of Archaea as suspected pathogens.
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Archaea in oral diseases 731. Introduction
Microorganisms were previously classified based on their phe-
notypic characteristics, such as morphological, Gram-staining,
energy uptake, or metabolic properties. However, modern
approaches for classification based on the primary structure
of their genes revealed a novel domain of living organisms
distinct from bacteria and eukaryotes. This third domain
proposed by Woese et al. [1] is now known as the Archaea.
Archaea are widespread in nature and are capable of
thriving even in extreme environments, such as hot springs,
salt lakes, and submarine volcanic habitats [2—4]. Archaea
are known to be ubiquitous microorganisms, living in close
association with plants and animals. They have genomic and
metabolic systems that are well adapted to their own habi-
tats. Archaea have been isolated from the human oral cavity
[5—7], gastrointestinal tract [8], and vagina [9]. Methano-
brevibacter is one such major genus found in humans. Metha-
nobrevibacter smithii is the predominant species in the
human gut with a genomic structure suitable for persistence
in this environment [10]. Methanobrevibacter oralis was
reported to be the dominant archaeal species in the oral
cavity [11—15]. Despite their ubiquity, diverse in nature,
abundance, and close association with humans, pathogenic
Archaea have not yet been identified. No studies have con-
clusively identified Archaea as causative agents of human
disease, and there is some discussion regarding whether
there are actually any pathogenic Archaea [16,17].
Periodontitis is an infectious, inflammatory disease of
periodontal tissue. Distinct from general infectious diseases,
such as cholera, periodontitis is a disease involving polymi-
crobial (mixed) infection by oral microorganisms. Rather
than a single species, several Gram-negative anaerobes
and spirochetes in the gingival sulcus (periodontal pocket)
have been established as periodontal pathogens [18]. How-
ever, advances in molecular microbiological analyses indi-
cated that many other organisms, including Gram-positive
bacteria, were associated with the pathogenesis of period-
ontitis [19]. In addition to bacterial species, modern
approaches using quantitative molecular detection methods
suggested the involvement of methanogenic Archaea. Lepp
et al. [15] reported that Archaea are specifically distributed
in sites of severe periodontitis, accounting for a high propor-
tion of the total prokaryotic population of subgingival pla-
que. This report prompted discussion regarding the
pathogenicity of Archaea, and attention has focused on
periodontitis as a potentially Archaea-associated disease.
This review presents a summary of recent studies regard-
ing the involvement of Archaea in oral infectious diseases. In
addition, the putative pathogenic role of Archaea is
addressed mainly from the viewpoint of antigenicity in per-
iodontitis, and future strategies for medical microbiological
studies of Archaea are discussed.2. Distribution and diversity of Archaea in
oral infectious diseases
2.1. Archaea in periodontitis
A methanogenic Archaea was isolated from subgingival pla-
que samples obtained from patients with periodontitis in
1988 [5]. The isolated methanogen was reported to be anti-
genically similar to that in the intestinal tract. The methane-
producing organism was subsequently named M. oralis [6],
although the classification of the Archaea domain was not
commonly accepted. Kulik et al. [7] demonstrated using a
molecular approach that M. oralis was the predominant
archaeon in subgingival dental plaque. In their study,
archaeal DNA was detected in 37 of 48 subgingival plaque
samples. There were no significant differences with respect
to clinical parameters between patients carrying plaque
containing or lacking Archaea. At that time, the majority
view was that there were no pathogenic Archaea. Most
researchers did not pay a great deal of attention to these
microorganisms with the idea that Archaea may be causative
agents of human diseases. However, this changed with the
medical microbiological approach to Archaea reported by
Lepp et al. [15] suggesting a probable pathogenic role of
Archaea in periodontitis. They reported that the relative
abundance of Archaea in subgingival plaque, dominated by
an M. oralis-like phylotype, increased in relation to the
severity of chronic periodontitis. Further, the methanogenic
Archaea were shown to be potential hydrogen competitors of
treponemes and suggested to possibly serve as syntrophic
partners with other members of the subgingival crevice flora.
These results suggested that Archaea could influence the
virulence of plaque through alteration of the plaque micro-
flora. Following this epochal report suggesting the patho-
genic significance of Archaea based on results obtained by
quantitative molecular methods, a series of studies investi-
gating the distribution and diversity of Archaea in oral infec-
tious diseases, mainly periodontitis and apical periodontitis,
have been reported.
Table 1 presents a summary of studies performed after
Lepp’s report investigating the distribution and diversity of
Archaea in periodontal pockets (subgingival plaque). Using
PCR-based methods and DNA sequence analysis of the PCR
products, these studies revealed the detection frequency,
relative abundance among the total prokaryotic population,
and dominant archaeal species. Subgingival plaque samples
were used in all cases. The detection frequencies of archaeal
genes varied among the reports ranging from 18.8% to 96.4%
in patients. These differences may have been due to geo-
graphic factors and genetic factors of the subjects. The
proportions of methane producers among the adult human
population in the USA and the UK (30—60% [20—22]) were
higher than those in Japanese subjects (10—15% [23,24]).
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AP: aggressive periodontitis; CP: chronic periodontitis; HC: healthy control; NA: not assessed; qPCR: quantitative PCR.
a Relative abundance in total prokaryotic community.
b Probing depth.
c Clinical attachment loss.
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genic Archaea in the gastrointestinal tract of Japanese sub-
jects was reported to be lower than in other countries
[24,25]. The low detection frequency of Archaea in subgin-
gival plaque of Japanese patients [13] may be due to similar
reasons. Another possible cause of the differences in detec-
tion frequency may be methodological discrepancies, espe-
cially in the DNA extraction steps and the primers used for
PCR. Horz et al. [26] used multiple PCR primer sets and
demonstrated that each of these primer set yielded different
results for the detection of Archaea even though they were
used in previous studies. As the specificity and sensitivity of
PCR are dependent on the primers used, a consensus regard-
ing the detection method must be established to allow
comparison of results between different groups. Combined
use of primer sets targeting different genes, mcrA and 16S
rRNA genes, is recommended to improve the accuracy of
experiments.
With regard to the presence of Archaea in relation to
disease condition, most recent studies yielded similar results
indicating that Archaea were specifically distributed to dis-
eased sites, especially in deep periodontal pockets (Table 1).
As methanogens require strict anaerobic conditions, coloni-
zation on the surface of the tongue or buccal mucosa is
theoretically impossible for these organisms. Shallow pock-
ets also cannot be habitats for methanogenic Archaea for the
same reason. A recent report by Matarazzo et al. [11] demon-
strated the high frequency of Archaea present in healthy
shallow gingival sulci. Further investigations are required to
determine whether these represent merely transient visitors
or colonizers. At present, it is generally thought that Archaea
are distributed in sites of periodontitis with deep periodontalpockets, although whether they are involved in the patho-
genesis of periodontitis remains a matter of debate.
Some recent studies also evaluated the relative abun-
dance of Archaea in the microflora of subgingival plaque.
Lepp et al. [15] reported that Archaea were the dominant
organisms with a relative abundance of 18.5% among the
total prokaryotic populations at severe diseased sites of
periodontitis (probing depth 6 mm). However, some sub-
sequent studies indicated that the percentages of Archaea in
the plaque population were lower than in Lepp’s report,
ranging from 0.08% to 0.5% (Table 1). The proportions of
hydrogenotrophs were below 1% in most cases [27]. In addi-
tion, in the presence of Fe3+ or SO4
2, sulfate-reducing
bacteria or iron-reducing bacteria have priority for the use
of hydrogen. These discrepancies may have been due to
methodological differences between the research groups.
However, considering the characteristics of subgingival
microflora and the fact that methanogenic Archaea are
terminal hydrogen consumers, the results of the latter
research are more reasonable than those reported by Lepp
et al. [15].
With regard to the diversity of Archaea, most previous
studies indicated that M. oralis and M. oralis-like phylotype
were the dominant archaeal species in subgingival plaque.
Compared to the bacterial community, which consists of
hundreds of species [27], only several archaeal species have
been reported previously in sites of periodontitis (Table 1).
Methanogens generally have synergistic relations with other
microorganisms in individual natural niches. Unfortunately,
the genome of M. oralis has not yet been analyzed, and the
details are still unclear. The low diversity indicates that
among archaeal species, M. oralis has genetic advantages
Archaea in oral diseases 75making it well adapted to the oral anaerobic environment in
relation to oral bacterial species. In addition to M. oralis,
Thermoplasmata, Methanosarcina, and Methanobacterium
spp. have been identified in plaque (Table 1). Horz et al. [26]
identified Thermoplasmatales and M. oralis in the same
plaque samples, suggesting that both types of Archaea can
coexist in an ecological niche. Further investigation and
discussion are required to determine whether the minor
archaeal species were transient visitors or inhabitants in
the gingival sulci. This question will be answered by quanti-
tative molecular analysis using species-specific primers.
2.2. Archaea in apical periodontitis
A series of studies have also been performed in endodontic
infection regarding the distribution and diversity of Archaea
(Table 2). Similar to periodontitis, the dominant archaeal
species in cases of endodontic infection were M. oralis and M.
oralis-like phylotype. The relative abundance of Archaea in
the total prokaryotic population was also similar to that
observed in subgingival plaque samples, ranging from
0.28% to 2.5%. However, the detection frequency showed a
striking difference compared to studies of periodontitis and
apical periodontitis, with the detection frequencies of
Archaea in endodontic infections being generally lower than
those in periodontitis (Table 2). A typical example was
reported by Siqueira et al. [28]. In their study, no archaeal
DNA was amplified by PCR from a total of 96 root canal
samples, including untreated and treated root canals asso-
ciated with asymptomatic chronic periradicular lesions, as
well as from cases diagnosed with acute periradicular
abscesses. This study concluded that members of the Archaea
domain are not members of the microbiota present in dif-
ferent types of endodontic infections and therefore may not
be involved in the etiology of apical periodontitis. In con-
trast, Jiang et al. [29] reported the presence of Archaea in
relation to clinical symptoms. In their study, the incidence of
symptomatic cases positive for both bacteria and Archaea
was significantly higher than that of those positive for bac-
teria alone. Methanogens must coexist with syntrophic part-
ners and interact closely with anaerobic bacteria in
individual niches in the natural environment, and probably
in the niches of the oral cavity. Indeed, it was reported thatTable 2 Detection of Archaea in root canals.
Tooth condition (sample no.) Isolated Archaea Detecti
frequen
Primary infection (32) M. oralis novel
methanogen
25% (8/
Primary infection (42) NA 38% (16
Secondary infection (35) 17% (6/
Symptomatic infection (20) M. oralis-like spp. 5% (1/2
Asymptomatic infection (14) 7% (1/1




qPCR: quantitative PCR; RT-PCR: reverse transcription PCR; NA: not ass
a Relative abundance in total prokaryotic community.Archaea were always found with bacteria in root canals [29].
Bacterial diversity in root canals [30] seems to be lower than
that in dental plaque. In addition, under the low-nutrient
conditions in the root canal, the microbiological community
may not be suitable for colonization by Archaea, which may
be responsible for their low detection frequency. Although
the reasons for the low detection rates of Archaea in root
canals remain to be elucidated, the chances for colonization
by Archaea in root canals are probably lower than in sites of
periodontitis. The presence of Archaea is not indispensable
for the initiation and progression of apical periodontitis, but
may be involved in the pathogenesis as observed for all other
established oral pathogens in polymicrobial infections.
Another remarkable recent finding was the syntrophic inter-
action of Archaea with Synergistes. Vianna et al. [31]
attempted to identify syntrophic partners of methanogens
in root canals and demonstrated the positive association
between the proportion of Synergistes spp. and methano-
gens. Interestingly, no association was found between the
suspected antagonistic partners, Treponema spp. and the
methanogens. Synergistes spp., known to be producers of
H2 and CO2, have been reported to show syntrophic interac-
tions with methanogens among the communities of anaerobic
sludge digesters [32]. These bacterial species may be key
players in Archaea-associated infections. In addition to per-
iodontitis and apical periodontitis, research regarding
Archaea has begun to extend to other oral infectious dis-
eases, such as periimplantitis or pericoronitis [33,34].
3. Pathogenic roles of Archaea
Medical microbiological approaches for Archaea have been
developed mainly in the field of dentistry. The association of
Archaea with oral infectious diseases was discussed based on
their distribution in diseased sites. Many previous studies
have investigated the distribution and diversity of Archaea in
periodontitis and apical periodontitis as described above. It is
now generally accepted that methanogenic Archaea are
members of the microbial communities in subgingival plaque
and root canals. Periodontitis and apical periodontitis are
caused by polymicrobial infection, and there is no single
causative agent with strong virulence. Even Porphyromonas
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relationship between a microbe and a disease. P. gingivalis is
widely distributed even in healthy subjects [13,35] and is not
always detected in diseased sites. There are no definitive
criteria for a periodontal pathogen. However, the results of a
number of studies have established the status of P. gingivalis
as a periodontal pathogen. Research performed to date has
confirmed the presence of Archaea in diseased sites. Medical
microbiological studies of Archaea are now required to
investigate the pathogenic roles of these organisms in the
mechanisms of oral infectious diseases.
3.1. Influence on microflora
Suspected pathogenic roles of Archaea are currently under
investigation mainly from two different viewpoints. The first
is their interactions with other microorganisms in the patho-
genic flora. Most methanogenic Archaea cannot live alone,
but coexist and interact closely with anaerobic bacteria both
in nature and in host animals. Methanogenic Archaea utilize
low molecular weight compounds, such as H2 + CO2, formic
acid, or acetate and therefore have symbiotic relationships
with the producers of these substrates. Interaction with
organisms responsible for fermentation [36,37] is a typical
example of such a symbiotic relationship (mutualism). On the
other hand, methanogenic Archaea have antagonistic rela-
tions with other H2 consumers. Therefore, it is reasonable to
hypothesize that the presence or increase in level of metha-
nogenic Archaea alters the composition of the polymicrobial
community thus resulting in changes in virulence of the flora.
Some attempts have been made to investigate the archaeal
influence on the composition of microflora at diseased sites.
Lepp et al. [15] demonstrated the antagonistic interactions
of methanogenic Archaea and treponemes, and Synergistes
spp. have been suggested to be possible syntrophic partners
of the methanogens [31]. From a clinical perspective,
increases in the population of methanogenic Archaea and
sulfate-reducing bacteria have been reported to be asso-
ciated with the severity of periodontitis [38]. It is generally
accepted that a large population of periodontal pathogens,
such as the red complex [18], increases the microbiological
risk in periodontitis. However, recent molecular analyses
indicated that the red complex species were detected in
diseased sites but at lower frequency than in previous studies
performed in culture [19]. The oral microflora is more diverse
than previously thought, and the range of research targets
has been expanded to include novel taxa, Archaea, and gram-
positive species [19]. Further detailed analyses of plaque
virulence itself will be required for evaluation of the patho-
genic role of Archaea through syntrophic interactions with
other bacterial species. Metagenomic analysis using high-
throughput sequencing methods has begun to be used to
determine the structures of bacterial communities and the
pangenome of plaque [39]. These approaches will facilitate
further studies of the roles of Archaea in the ecosystem of the
virulent plaque.
3.2. Antigenicity of Archaea
The virulence of periodontal pathogens is currently investi-
gated through ‘‘host—parasite interactions’’ rather thanspecific virulence factors. Microorganisms associated with
periodontitis do not have strong virulence or virulence fac-
tors that initiate and induce the progression of disease alone.
The mass of the polymicrobial community in subgingival
plaque induces host immune responses (inflammation) that
cause bone loss and tissue destruction. Within the commu-
nity, organisms frequently isolated from the diseased sites
with antigenic properties to induce relatively strong inflam-
matory responses, are considered to be periodontal patho-
gens. Methanogenic Archaea may not have strong virulence,
but they have an ample chance to come into contact with the
human immune system. In addition to the influence on
microflora, characterization of the antigenic properties of
Archaea is essential to investigate their pathogenic roles.
There have been only a few previous investigations of the
antigenicity of oral methanogens. Our group examined the
humoral immune response to M. oralis using sera from
patients with periodontitis [13]. In the results of Western
immunoblotting in this study, multiple antigenic bands
showed reactivity with patients’ sera, indicating that the
host immune system had been exposed to Archaea in period-
ontal lesions. Our group identified one of the archaeal anti-
gens in a follow-up study [40]. The identified molecule was a
group II chaperonin subunit protein, and cross-reactivity with
human group II chaperonin (CCT) was demonstrated. Cross-
reactivity between bacterial GroEL and human HSP60 (group I
chaperonin) is well known in relation to autoimmune reac-
tions and diseases [41]. Bacteria have group I but not group II
chaperonins. Most archaeal species possess group II chaper-
onins alone, while eukaryotes have both types. As it was
originally thought that there were no pathogenic Archaea,
attention was focused only on group I chaperonins as provid-
ing a link between infectious disease and autoimmune
responses. However, the human chaperonin CCT has been
reported to be an autoantigen [42]. Thus, the chaperonins of
Archaea may act as cross-reactive antigens in the pathogen-
esis of periodontitis. In addition to oral diseases, the immu-
nogenic properties of Archaea in bioaerosols were recently
reported, and an immunomodulatory role in the pulmonary
tract was suggested [43]. Another component that may play a
role in the inflammatory response of periodontal lesions is a
class of archaeal membrane lipids, known as archaeosomes,
which have been reported to act as potent immune adjuvants
[44]. The polar lipids present in the periodontal region with
other bacterial pathogens may enhance the inflammatory
responses to their antigens. Although further investigations
are needed before definitive conclusions can be reached,
Archaea with antigenic molecules and unique membrane
lipids have the potential to at least act as modifiers (mod-
ulators) of inflammatory processes in periodontal lesions.
4. Conclusions
Medical microbiological approaches to Archaea should shift
from investigations of their distribution to the study of their
pathogenic roles. As Koch’s postulates are not applicable to
oral infections with complicated microflora, multiple angles
will be required for analysis of the pathogenic roles of certain
microorganisms. Such studies should include metagenomic
analyses, examination of cytokine induction, and elucidation
of the adjuvant activity of archaeosomes. Especially, genome
Archaea in oral diseases 77analysis of M. oralis is urgently required and will be essential
to determine the virulence and metabolic properties of this
organism. Although the pathogenic roles are now mainly
discussed from the viewpoint of synergistic interactions with
oral bacteria, Archaea with unique membrane lipids and
cross-reactive antigens with human CCT have the potential
to be causative agents, or at least modulators (modifiers), of
immune and inflammatory responses in these lesions. Deter-
mination of the complicated ‘‘host—parasite interactions’’
will be important to gain an understanding of the role of
Archaea as pathogens in polymicrobial infectious diseases.
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